Aurigene Discovery Technologies Limited
Clinical trials sponsored by Aurigene Discovery Technologies Limited, explained in plain language.
-
New pill aims to tame advanced lymphomas in early trial
Disease control Recruiting nowThis early-stage study tests an experimental oral drug called AUR108 in adults with relapsed advanced lymphomas. The main goals are to check the drug's safety, find the right dose, and see how the body processes it. About 40 participants will take the pill, and researchers will m…
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Apr 26, 2026 19:38 UTC
-
New pill AUR112 tested in patients with returning lymphoma
Disease control Recruiting nowThis early-stage study tests an experimental oral drug called AUR112 in about 40 adults with relapsed advanced lymphoma (a type of blood cancer that has come back). The main goals are to check the drug's safety, find the right dose, and see how the body processes it. Participants…
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Apr 24, 2026 16:06 UTC
-
New cancer pill tested in patients who have run out of options
Disease control Recruiting nowThis is the first study in people to test a new oral medication called AUR107 for advanced solid tumors that have come back after other treatments. The main goals are to check the safety of the pill, see how the body processes it, and find the best dose for future studies. It is …
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC
-
New pill tested for patients out of options against advanced blood cancers
Disease control Recruiting nowThis is a first-in-human study testing a new oral drug called AUR104 in adults with certain advanced lymphoid cancers that have come back or stopped responding to standard treatments. The main goal is to find a safe and tolerable dose by gradually increasing it in small groups of…
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Apr 15, 2026 16:15 UTC